Health Condition 1: A488- Other specified bacterial diseases
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
InBios International, Inc.
Eligibility
Inclusion criteria
Inclusion criteria: Participants aged 2 years and above at the time of enrolment Participants or their legally acceptable representative willing and able to provide written informed consent or assent as per local guidelines Patients presenting with clinical features suggestive of melioidosis including sepsis of unknown cause or clinically suspected melioidosis as documented by the treating physician Patients from melioidosis endemic regions as determined by the treating physician
Exclusion criteria
Exclusion criteria: Patients who have received antibiotics active against Burkholderia pseudomallei for more than 48 hours prior to enrolment Previous enrolment in this study Inmate or deprived of freedom by court order
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PPA and NPA of AMD Plus vs reference standardTimepoint: At baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Performance stratified by sample type, antibiotic exposure status, & time since symptom onsetTimepoint: At baseline | — |
Countries
India
Contacts
Public ContactDr Chiranjay Mukhopadhyay
Kasturba Medical College, Manipal
Outcome results
None listed